In a clinical study, Vyvanse provided consistent ADHD symptom control throughout the day based upon parent reports in the morning (approximately 10am), afternoon (approximately 2pm), and early evening (approximately 6pm).
Shire says these results may be of interest to mothers of children with ADHD based on a recent survey of 121 mothers of ADHD children aged six to 12 years, in which 60% of mothers reported that their child’s ADHD medication stopped working before 6pm, and 40% reported that their child’s ADHD medication stopped working before 4pm.
“Vyvanse was shown in clinical studies to provide physicians with a treatment option for ADHD that offers consistent and effective control of ADHD symptoms throughout the day for up to 12 hours, from morning through homework and family time,” said Frank Lopez, managing director of the Children’s Developmental Center. “Consistent symptom control throughout the day is important because kids have homework and after-school activities that require the same concentration and focus needed during the school day.”
Vyvanse works with the patient’s natural metabolism to deliver active medication and improves core ADHD symptoms of inattention (eg. focus, listening to, and following instructions) and behavior (hyperactivity and impulsivity).
The FDA approved the drug on February 23, 2007. It is now available in retail pharmacies in 30mg, 50mg and 70mg dosage strengths.